Inhibikase Therapeutics Inc. announced the election of Dr. Hilary Malone, current Chief Regulatory Officer, Sanofi, to its Board of Directors. Dr. Steven R. Gilman has retired from the Board after nearly four-and-one-half years of service. Prior to joining Sanofi, Dr. Malone held roles as the Senior Vice-President and Head of Worldwide Regulatory Strategy for both Pfizer and Wyeth.